Core Laboratories CLB Operating Segment Production Enhancement — Operating Income
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Core Laboratories in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Core Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Core Laboratories's operating segment production enhancement — operating income.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Core Laboratories's operating segment production enhancement — operating income?
- Core Laboratories (CLB) reported operating segment production enhancement — operating income of $804K in Q1 2026.
- How has Core Laboratories's operating segment production enhancement — operating income changed year-over-year?
- Core Laboratories's operating segment production enhancement — operating income decreased by 46.5% year-over-year, from $1.5M to $804K.
- What is the long-term trend for Core Laboratories's operating segment production enhancement — operating income?
- Over 3 years (2021 to 2025), Core Laboratories's operating segment production enhancement — operating income has grown at a -7.4% compound annual growth rate (CAGR), from $15.16M to $12.06M.
- What does operating segment production enhancement — operating income mean?
- This metric represents the profit or loss generated by the production enhancement segment after deducting all operating expenses from its revenue. It is a key indicator of the segment's operational efficiency and core business profitability.